6 days ago
37
A large randomized trial suggests that newer blood thinners can significantly reduce serious cardiovascular events in people with atrial fibrillation who face an intermediate risk of stroke.
The findings come from the SINGLE-AF trial, presented during a Hot Line session at ESC Congress 2026 and published at the same time in the New England Journal of Medicine. Compared with receiving no anticoagulant therapy, treatment with oral anticoagulants was ass...
English (US) ·